Alirocumab

An antibody called "alirocumab" can significantly lower cholesterol levels in patients with an inherited disease associated with very high levels of low density lipoprotein cholesterol (LDL-C) or what is called "bad" cholesterol, new research has found.

According to a new study, an antibody called "alirocumab" can significantly lower cholesterol levels in patients with very high levels of low density lipoprotein cholesterol (LDL-C) or what is called "bad" cholesterol.

An antibody called "alirocumab" can significantly lower cholesterol levels in patients with an inherited disease associated with very high levels of low density lipoprotein cholesterol (LDL-C) or what is called "bad" cholesterol, new research has found.

According to a new study, an antibody called "alirocumab" can significantly lower cholesterol levels in patients with very high levels of low density lipoprotein cholesterol (LDL-C) or what is called "bad" cholesterol.